Andrea Feigl-Ding, PhD MPH, is a global health economist at Harvard Medical School, Department of Global Health and Social Medicine, and Senior Health Economist at Microclinic International.
Her research focuses on health financing and governance, universal healthcare and cost-effectiveness of chronic disease interventions in developing countries. Her works include leading the largest worldwide longitudinal analysis of the political, social, and economic determinants of universal healthcare in 196 countries (published in Health Policy), leading the impact evaluation of a nationwide anti-smoking legislation in Chile (published in WHO Bulletin), and leading the impact study of the award-winning intervention program for obesity/diabetes prevention in Amman, Jordan (project awarded Global Health Project of the Year from Consortium of Universities for Global Health). She is also recognized as the innovator of the Evidenced Formal Coverage Index metric for universal healthcare coverage, focused on comparative health economics of achieving UHC.
In addition to working on health systems issues in Timor-Leste and Bangladesh, she previously conducted policy research at WHO-PAHO, evaluating IMCI (Integrated Management for Childhood Illness) projects in Ecuador, Paraguay, and Peru, worked for the Canadian Institutes of Health Research, and worked on international maternal-child health research at the University of Oxford. She has authored several high level reports, including Development Aid Flows for Chronic Diseases for the Center for Global Development, a background paper on the political economy of universal healthcare for WHO, and a leading World Economic Forum/Harvard report on the global economic burden of chronic diseases, featured at the UN High Level Summit on NCDs in 2011.
She was a Harvard Graduate Leadership Initiative Fellow, former President of the Harvard Club of Austria, and an internationally certified teacher in Cecchetti classical ballet from the Imperial Society for Teachers of Dance. A native of Austria, she received her PhD in global health from Harvard University, her MPH and BSc (First Class Honors) with a full scholarship from Simon Fraser University in Canada, and was a graduate of the Red Cross Nordic United World College in Norway.